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Background: Honduras is a tropical country with more than 70% of its population living at risk of being infected
with either Plasmodium vivax or Plasmodium falciparum. Laboratory diagnosis is a very important factor for adequate
treatment and management of malaria. In Honduras, malaria is diagnosed by both, microscopy and rapid diagnostic
tests and to date, no molecular methods have been implemented for routine diagnosis. However, since mixed
infections, and asymptomatic and low-parasitaemic cases are difficult to detect by light microscopy alone,
identifying appropriate molecular tools for diagnostic applications in Honduras deserves further study. The present
study investigated the utility of different molecular tests for the diagnosis of malaria in Honduras.
Methods: A total of 138 blood samples collected as part of a clinical trial to assess the efficacy of chloroquine were
used: 69 microscopically confirmed P. falciparum positive samples obtained on the day of enrolment and 69 follow-
up samples obtained 28 days after chloroquine treatment and shown to be malaria negative by microscopy.
Sensitivity and specificity of microscopy was compared to an 18 s ribosomal RNA gene-based nested PCR, two
single-PCR reactions designed to detect Plasmodium falciparum infections, one single-PCR to detect Plasmodium
vivax infections, and one multiplex one-step PCR reaction to detect both parasite species.
Results: Of the 69 microscopically positive P. falciparum samples, 68 were confirmed to be P. falciparum-positive by
two of the molecular tests used. The one sample not detected as P. falciparum by any of the molecular tests was
shown to be P. vivax-positive by a reference molecular test indicating a misdiagnosis by microscopy. The reference
molecular test detected five cases of P. vivax/P. falciparum mixed infections, which were not recognized by
microscopy as mixed infections. Only two of these mixed infections were recognized by a multiplex test while a P.
vivax-specific polymerase chain reaction (PCR) detected three of them. In addition, one of the day 28 samples,
previously determined to be malaria negative by microscopy, was shown to be P. vivax-positive by three of the
molecular tests specific for this parasite.
Conclusions: Molecular tests are valuable tools for the confirmation of Plasmodium species and in detecting mixed
infections in malaria endemic regions.* Correspondence: NLucchi@cdc.gov
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Honduras is a tropical country with more than 70% of
its population living at risk of malaria infections. Al-
though malaria control efforts have led to substantial re-
duction in the number of malaria cases in Central
America, low-level transmission of both Plasmodium
vivax and Plasmodium falciparum continues to occur. In
Honduras, P. vivax is responsible for the largest number
of malaria cases while P. falciparum accounts for 10-15%
of the cases reported [1] and causes a more severe clin-
ical presentation. About 8,000 to 9,000 malaria cases are
reported annually, with some fluctuations in the last two
years. Microscopy is the most commonly used method of
malaria diagnosis. Recently, rapid diagnostic tests (RDTs)
were introduced, but their use is currently limited to sur-
veillance studies except in very remote areas where they
are used for routine clinical diagnosis with a mandatory
microscopic confirmation.
Microscopic detection of malaria parasites is a stand-
ard method for the diagnosis of malaria because of its
sensitivity, specificity, and ability to quantify the parasit-
aemia level [2,3] under ideal conditions. It is also less ex-
pensive than many other malaria diagnostic tools. In
Honduras, microscopy has remained a commonly used
diagnostic method for malaria. However, one of the lim-
itations of microscopy is that sometimes it may be diffi-
cult to identify the species correctly, especially when
slides are not properly prepared or the user has limited
training. Microscopy can also fail to detect mixed infec-
tions especially when one of the infecting species is
present at low levels. Therefore, molecular tests have
been used as complementary tools for the diagnosis of
malaria in some reference laboratories so that accurate
diagnosis can be made. Recent efforts to eliminate mal-
aria, in low-transmission areas such as Central America,
have increased the need for introducing molecular tools
with high sensitivity capable of detecting sub-clinical
levels of parasitaemia in asymptomatic carriers. In recent
years, several different polymerase chain reactions
(PCR)-based malaria diagnostic methods have been
developed [4-9]. Many of these methods have shown
ability to detect mixed infections and infections with low
parasitaemia [10-12], and most of these methods have
been found to be more sensitive than microscopy
[11,13].
In this study, the utility of five different molecular tests
were investigated for the retrospective detection of 138
microscopically diagnosed samples obtained from a clin-
ical study conducted in Honduras. A commonly used
nested PCR test based on the amplification of 18 S ribo-
somal RNA gene was used as reference test [14]. Other
tests included a multiplex PCR for the detection of both
P. falciparum and P. vivax parasites and three single-
tube species-specific (two P. falciparum-specific and a P.vivax-specific test) PCR tests. All these tests, except the
nested PCR, were recently developed using novel gen-




A total of 138 blood samples (about 50 μl each) were
collected and stored on Whatman filter paper number 3
for molecular testing. These samples were collected in
2009 in the eastern Honduran region of Gracias a Dios
as part of a clinical trial to assess the efficacy of chloro-
quine. Only patients with P. falciparum mono-infection,
as diagnosed by light microscopy, were included in this
study. A total of 69 patients were enrolled. The patients’
blood samples were obtained on the day of enrolment
(day 0 samples) and 28 days after chloroquine treatment
(day 28 samples). Of note, P. vivax infections were not
included in this clinical study.
Ethical approval
The study was approved by the Ethics Committee of the
Medical Sciences Faculty of the National University of
Honduras (UNAH-IRB 00003070). Informed written
consent forms were obtained from each participant.
Microscopy
Blood smears were stained with 3% Giemsa for 30 min-
utes at room temperature. Smears were analysed by
experienced microscopists from the Honduras National
Malaria Programme. The standard method recom-
mended by the World Health Organization (WHO) was
carried out in order to estimate the number of circulat-
ing parasites per μl of blood. As white blood cell (WBC)
count was not available for every patient, concentration
of 6,000 leucocytes ml-1 were used to estimate parasit-
aemia levels.
DNA extraction
The DNA was extracted from dried blood spots using a
commercial kit (Qiagen, Valencia, CA, USA) following
the manufacturer’s instructions. The DNA was eluted in
200 μl of buffer and stored at −20°C until used.
Nested PCR
The reference 18 s ribosomal RNA gene-base nested
PCR was performed with primers and cycling conditions
as described by Singh et al [16] with some modifications.
Briefly, reactions were performed in 25 μL total volume
containing 1X buffer, 2.5 mM MgCl2, 200 μM dNTPs,
200 nM primers, and 1.25 units of Taq Polymerase (New
England Biolabs, Ipswich, MA, USA), and 1-3 μl of
DNA template. The genus-specific PCR was followed
by P. falciparum and P. vivax species-specific PCR
Table 1 Primers and PCR conditions used for the different molecular tests evaluated
Test (species) Primer ID Primer sequence 5′-3′ Annealing temperature Size (bp)
Test 1 (Pf)* AL7178 CCGGAAATTCGGGTTTTAGAC 60°C 220
AL7142 GCTTTGAAGTGCATGTGAATTGTGCAC
Test 2 (Pf) AL7140 CCATTTTACTCGCAATAACGCTGCAT 57°C 716
AL7141 CTGAGTCGAATGAACTAGTCGCTAC
Test 3 (Pf/Pv) AL7178AL7142 CCGGAAATTCGGGTTTTAGACGCTTTGAAGTGCATGTGAATTGTGCAC 60°C 333/220
AL7175 CTGATTTTCCGCGTAACAATG
AL7074 CAAATGTAGCATAAAAATCYAAG
Test 4 (Pv)* AL7175 CTGATTTTCCGCGTAACAATG 54°C 333
AL7074 CAAATGTAGCATAAAAATCYAAG
Table 1 shows the primer ID and sequence and PCR conditions used for the novel molecular test used to detect Plasmodium falciparum (Pf) and/or Plasmodium
vivax (Pv). *Primers used in the multiplex Test 3
Table 2 Sensitivity and specificity of the novel primers to
detect Plasmodium falciparum compared to the reference
nested PCR






Positive Negative Positive Negative Positive Negative
Positive (68) 68 0 63 5 66 2
Negative (68) 0 68 0 68 0 68






Specificity 100% (CI: 93.4-100) 100% (CI: 93.4-100) 100% (CI: 93.4-
100)
The nested PCR test was used as a reference test. Test 1 and Test 2 are specific
to Plasmodium falciparum (Pf). Test 3 is a multiplex test designed to detect
both Plasmodium falciparum and Plasmodium vivax (Pv). 68 parasite negative
samples were identified as negative by all the tests
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in each reaction. All PCR assays were amplified on a
BioRad iCycler (BioRad, Hercules, California). Ampli-
cons from the second PCR were separated by electro-
phoresis on a 2% agarose gel and stained with ethidium
bromide for visualization using ultraviolet trans-
illumination. The presence of parasitaemia was con-
firmed when the expected band size corresponding to P.
falciparum and P. vivax were present.
Un-nested multiplex and single-tube species-specific PCRs
Various primers used for the different tests are provided
in Table 1 and were based on a previous study [15]. Test
1 (primers AL7178/AL7142) and Test 2 (primers
AL7140/AL7141) were single tube un-nested PCR tests
specific to P. falciparum. Test 3 was a multiplex un-
nested PCR to detect both P. falciparum and P. vivax
using specific primers (AL7178/AL7142 and AL7175/
AL7074, respectively). Test 4 was an un-nested P. vivax
specific test (primers AL7175/AL7074). Amplifications
were performed under the following amplification condi-
tions in a 25 μl volume: 1X Taq Buffer (New England
Biolabs, Ipswich MA, USA), 4 mM MgCl2, 400 μM each
dNTP, 500 nM each primer, 2.5 units of Taq DNA Poly-
merase (New England Biolabs, Ipswich, MA, USA), and
1-3 μl of DNA template. Reactions were amplified by an
initial denaturation at 95°C for 2 min, 35 cycles of 95°C
for 30 sec, annealing temperature for 30 sec, and 72°C
for 45 sec, with a final extension at 72°C for 5 min.
Amplicons were visualized by 2% agarose gel electro-
phoresis with ethidium bromide. Each molecular test
was performed two times. If a discordant result was
obtained, the experiment was repeated a third time and
the final result was determined by two concordant tests.
Results and conclusions
Molecular tests for malaria diagnosis have repeatedly
been shown to be more sensitive and accurate in detect-
ing malaria parasites compared to microscopy [17,18]. Inthis study, 69 microscopically confirmed P. falciparum-
positive samples and 69 samples obtained after day 28 of
chloroquine treatment (microscopically found to be
negative for malaria parasites) were used to test the util-
ity of four novel molecular tests for malaria diagnosis.
The results of these different tests were compared to the
reference nested PCR test (Table 2). Of the 69 micro-
scopically positive P. falciparum samples used in this
study (parasite count range 320–120,000 parasites/μl),
68 were confirmed to be P. falciparum-positive by the
reference nested PCR test and Test 1. One sample
(PL3333), which was found to be P. falciparum by
microscopic examination, was not confirmed to be
positive by any of the P. falciparum molecular tests
used. Interestingly, the same sample was found to be
P. vivax-positive by the reference nested PCR test and
two other molecular P. vivax tests used (Test 3 and
Test 4). This finding suggests that this sample was
misdiagnosed as P. falciparum by microscopy.
Interestingly, the reference nested PCR test detected
the presence of P. vivax/P. falciparum mixed infections
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reported on the fact that mixed infections are often not
recognized or are underreported [19-22], mainly due to
the limitation of detection tools employed [22]. The
current study confirms these previous studies and
demonstrates that low-level mixed infections are indeed
common and molecular tools are needed to detect them.
In addition, one of the day 28 samples, previously diag-
nosed as malaria negative by microscopy, was clearly
identified to be P. vivax using the reference nested PCR
test. This finding was confirmed by the other tests
designed to detect P. vivax (Test 3 and Test 4). This
finding again highlights the importance of using comple-
mentary molecular tests for species confirmation as
needed.
The performance of Test 1 was comparable to that of
the reference nested test in detecting all P. falciparum
infections (Table 2). On the other hand, Test 2 showed
lower sensitivity as compared to both the reference
nested PCR test and Test 1. This finding suggests that
Test 1 is a better alternative to the reference nested PCR
test for detecting P. falciparum as it does not require
two rounds of PCR, which often leads to risks of con-
tamination and is more expensive and time consuming
[11]. Since Test 2 showed the lowest sensitivity for P.
falciparum detection, it may not be a good comple-
mentary test unless its sensitivity can be improved with
further alterations.
The multiplex Test 3 was 97.1% sensitive in detecting
P. falciparum infection compared to the reference nested
PCR test (Table 2). This test also detected two of the five
P. vivax mixed infections detected by the reference
nested PCR test. Although the multiplex Test 3 needs
further improvement to increase its sensitivity, it has
performed better than previously described nested multi-
plex PCR tests [8,23].
Test 4, which was a P. vivax-specific test, detected
four of the six P. vivax-positive samples detected by
the reference nested PCR test. Sensitivity and specifi-
city of this test were not calculated since the number
of P. vivax samples was too low to undertake this
evaluation. Five of these samples were shown to be
mixed infections with P. falciparum and the other one
was shown to be a P. vivax sample. The fact that these
P .vivax/P. falciparum mixed samples were not detected
by microscopy as mixed infections to begin with, may indi-
cate that the P. vivax parasitaemia may be too low in these
samples and therefore, below the detection limit of this
test. It is known that the density of P. vivax infection in
general is low compared to P. falciparum and, conse-
quently, a highly sensitive PCR test similar to the reference
nested PCR test will be required to detect mixed infections
correctly. Although further optimization is required to im-
prove the sensitivity of Test 4, it is noteworthy that thistest was able to detect four of the P. vivax samples that
microscopy did not detect.
As illustrated by results from this study, one of the
most notable advantages of molecular methods is their
higher sensitivity to detect mixed infections and to iden-
tify species of malaria parasites accurately. Therefore,
while light microscopy is still a convenient technique for
the routine malaria diagnosis in countries like Honduras,
molecular tests are suitable complementary tests for the
confirmation of species and to detect mixed infections in
special studies such as drug efficacy clinical trials.
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